A brief history of Agaricus blazei Murril mushroom
Agaricus blazei Murril was first noticed about 30 years ago when two researchers from Penn State University visited Piedade city, in Saint Paul state-Brazil and discovered that the natives were very healthy with very low rates of disease and that a disproportionately high number enjoyed longevity.
A Japanese-Brazilian farmer first discovered the Agaricus blazei Murril mushroom in the summer of 1965. Since 1968, Dr. Takashi Mizuno Ph.D., has studied the bioactive substances in fungi, especially those related to anti-tumor active polysaccharides.
They discovered that the Agaricus blazei Murril was rich in polysaccharide compounds, which assist in boosting the immune system. Research has found that the two principal polysaccharide compounds, which exist in Agaricus Blazei Murril, are ß(Beta) 1,3-D Glucan and ß(Beta) 1,6-D Glucan.
During the 1980's and 1990's scientists conducted studies that have shown the Agaricus blazei Murril mushroom to be an immune system stimulant which promotes the body's natural defense mechanisms to fight a variety of infectious agents, including cancer. The polysaccharide contained in Agaricus Blazei Murill vitalizes production of interferon and interleukin. This effect indirectly functions to destroy or prevent the proliferation of cancer cells. This refers to a cytosine inducing effect. Moreover, the experiments conducted by the researchers named above proved that this effect can also prevent viruses and other external factors from entering the tissue.
Clinical results, obtained in collaboration with university researchers and hospitals since the report on the anti-cancer effect of Agaricus blazei Murril was released at the general convention of the Japan Cancer Association in 1980, proved that many fungi polysaccharides only effect solid cancer and the polysaccharide of Agaricus blazei Murril is effective against Ehrlich's ascites carcinoma, sigmond colonic cancer, ovarian cancer, breast cancer, lung cancer, and liver cancer, as well as against solid cancer.
Can you benefit from supplementing with Cuesta Agaricus mushrooms ?
Everyone can benefit from enhancement of his or her immune system to provide a longer and better quality life. All of us are subjected to the immune suppressing action of aging, environmental contaminants, chemicals in food and water, disease and the stresses of a fast paced lifestyle. Cuesta Agaricus mushrooms are nutritional dietary food supplements with an active ingredient proven by research to be an incredibly effective enhancing agent to the immune system.
Based on research on the active ingredients in Agaricus blazei Murril mushrooms, the following people may obtain beneficial results from Cuesta Agaricus mushrooms due to active ingredient, b-1,3 and b-1,6-glucan:
Men, women and children with an impaired or suppressed immune system from any cause.
Men, women and children with a high occurrence of infectious diseases, including colds and flu.
Persons with allergies or skin inflammations.
Men, women and children undergoing chemotherapy and/or radiotherapy.
Persons over 40 at the age the immune function begins to slow due to the natural aging process.
Men and women affected by extra free radical production from external sources such as UV radiation, electromagnetic fields, poor nutritional habits and toxic chemicals.
Individuals with chronic diseases such as diabetes, chronic inflammation and chronic fatigue.
Professional and amateur athletes, or anyone who works out intensively.
Persons under physical or emotional stress.
Men or women with high risk of atherosclerosis. Macrophage activation, enhanced by the active ingredient in Agaricus blazei Murril, helps draw extra cholesterol from the blood; thus preventing further plaque formation on the arterial walls. The macrophage phagocytize (swallow up) existing plaque recognized as a foreign body in the arterial walls